## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.0% in lower entry zone (3.0-6.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (0.9%) confirms momentum alignment. Strong momentum (+1.8% 5-day acceleration).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($72.74)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Assenagon Asset Management S.A. Increases Stake in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251217T083138 | Somewhat-Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in Monster Beverage Corporation in Q3, now owning 0.31% of the company valued at $203.97 million. Despite recent insider selling, analysts maintain a "Moderate Buy" consensus rating with an average target price of $71.64. Monster Beverage reported strong Q3 earnings, beating estimates with $0.56 EPS and revenue of $2.20 billion, up 16.8% year-over-year.

**2. Monster Vs. Celsius: As Consumers Ditch Soda And Booze, Which Energy Drink’s Stock Is Winning?**
- Source: Stocktwits | 20251216T120833 | Somewhat-Bullish | Relevance: 100%
- As consumers increasingly opt for healthier beverage choices, the energy drink market is booming, with Monster and Celsius emerging as major contenders. While Monster offers stable leadership and global reach, Celsius is favored by analysts due to its aggressive growth and high potential despite a recent stock dip. Celsius's strategic acquisitions and strong revenue growth indicate it is currently outperforming Monster in stock performance.

**3. Corient Private Wealth LLC Has $98.17 Million Stock Holdings in Monster Beverage Corporation $MNST**
- Source: MarketBeat | 20251216T104219 | Bullish | Relevance: 100%
- Corient Private Wealth LLC significantly increased its stake in Monster Beverage Corporation (NASDAQ:MNST) by 101.8% during the second quarter, now owning 1,567,140 shares valued at approximately $98.17 million. Analysts maintain a "Moderate Buy" consensus with a $71.64 target price. Monster Beverage recently surpassed earnings estimates with an EPS of $0.56 and revenue of $2.20 billion, demonstrating strong financial performance.

**4. Goldman Sachs, Capital One Financial And A Consumer Defensive Stock: CNBC's 'Final Trades'**
- Source: Benzinga | 20251217T133515 | Somewhat-Bullish | Relevance: 85%
- Malcolm Ethridge of Capital Area Planning Group recommended Goldman Sachs (NYSE: GS) following its agreement to acquire Innovator Capital Management for $2.0 billion. Stephanie Link of Hightower Advisors suggested Capital One Financial (NYSE: COF), citing an Outperform rating and $270 price target from Wolfe Research. Joseph M. Terranova of Virtus Investment Partners selected Monster Beverage Corporation (NASDAQ: MNST), which received a maintained Buy rating and an increased price target of $82 from Stifel.

**5. Will Clorox's Pricing Power Hold as Consumer Elasticity Tightens?**
- Source: TradingView — Track All Markets | 20251216T170805 | Somewhat-Bullish | Relevance: 64%
- Clorox is facing a challenging consumer environment where pricing power is tested by value-seeking behavior. The company is adapting by using price pack architecture and targeted promotions, alongside expanding smaller pack sizes and offering dilutable cleaners, to maintain affordability while focusing on premium options for convenience. Despite these efforts, margin pressure continues due to higher costs and ERP-related disruptions, although the company's diversified strategy aims to maintain brand health and selective pricing resilience.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 7, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Citigroup | $87 | $82 | +6% |
| 2025-12-12 | Stifel | $82 | $78 | +5% |
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |
| 2025-12-03 | Wells Fargo | $83 | $75 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Citigroup | main | Buy |
| 2025-12-12 | Stifel | main | Buy |
| 2025-12-03 | Piper Sandler | main | Overweight |
| 2025-12-03 | Wells Fargo | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.84M) |
| Sells | 4 ($6.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Insider selling cluster: $6.1M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 7 raises (avg +13%) could attract flows.
- Momentum building: MRS_10 improving +1.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.76 elevated, pricing in significant growth expectations. Forward P/E 33.9x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (7 raises, avg +13%). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $73.7B |
| Beta | 0.48 |
| 52W Range | $45.70 - $76.28 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.76 |
| Forward P/E | 33.9 |
| Current P/E | 38.4 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 1.2% to 3.0% (+1.8% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 0.9% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +FTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.03% (CS: 83) | Strong |
| RSI_14 | 61.1 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 1.018x | Above |
| vs SMA50 | 1.059x | Above |
| vs SMA200 | 1.182x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $75.46
- **Stop Loss:** $72.74 (3.6% risk)
- **Target:** $79.54 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 261
- **Position Value:** $19,695.06
- **Portfolio %:** 19.70%
- **Risk Dollars:** $712.50
- **Risk Per Trade:** 0.71%
- **Modifiers:** L1 95% | L2 75% | Combined 0.71x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*